Background - Locations - Los Angeles

ACI - 3rd West Coast Edition - “Paragraph IV Disputes”

December 4-5, 2012 • San Francisco, CA

The must-attend event for litigators from brand name and generic companies to share insights into increasingly high-stakes and complicated Hatch-Waxman litigation.

At American Conference Institute’s 3nd Annual West Coast edition of its acclaimed Paragraph IV Disputes conference, an experienced faculty of renowned litigators and judges will guide you through every stage of a Paragraph IV challenge. They will help you formulate the offensive moves and defensive plays for the next round in the no-holds barred fight for pharmaceutical product market share. Additionally, in the wake of major developments in pay-for-delay, learn what the Federal Trade Commission deems foul and fair in the settlement of Paragraph IV disputes in order to draft and structure a settlement that will receive FTC approval.

At this industry-leading conference, our West Coast delegates will gain the tools to advance a novel claim or defense to protect patents and market share. They will have access to the expertise of trial leading patent counsel from generic and branded companies. They will also have the opportunity to hear from judges – who have experienced the intricacies of Hatch Waxman litigation first hand. Featuring an up-to-the-minute analysis of the latest game-changing case law developments regarding inequitable conduct, inducement of infringement and the standard of invalidity, this conference will give our attendees the strategies they need to help both brand name and generic companies protect market share and ultimately profits.

Mark Jansen is the moderator on the topic, "Controversies Surrounding Damages and Injunctions Relative to At Risk Launches."  Jim Stronski is one of the speakers on the topic entitled, "Updating the Standards in Inequitable Conduct Post-Therasense: Ethical Considerations for Paragraph IV Cases."